Fig. 2From: Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control studyPercentage of control group patients receiving insulin (left panel) and percentage of empagliflozin treated patients receiving insulin (right panel) during the first week in ICU. In control group patients, day zero is the day of ICU arrival. In treatment group patients, day zero is the day when empagliflozin treatment was initiatedBack to article page